Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
27
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 43%
💰 Capital Raise
model 55%
• Critical: only 1.4 months cash remaining
🔄 Reverse Split
model est. 45%
• 50-day avg $1.69 approaching $1 threshold
• Only 1 months cash — financial pressure
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$4.21M
Shares Outstanding2.55M
Float1.86M
Cash$2.92M
Debt$32.95M
Short InterestN/A
Institutional Holdings
3.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2026-03-31
xbrl
XBRL WARRANT
2025-12-31
8-K
8K EVENT
2026-02-24
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual APTOF Dilution Snapshot
Aptose Biosciences Inc. (APTOF) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for APTOF: xbrl on 2026-03-31; 8-K on 2026-02-24; xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: